STIM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Neuronetics Inc (STIM) is not a strong buy for a beginner, long-term investor at this moment. While there are some positive catalysts such as revenue growth and strategic discussions, the company's financial performance, lack of clear trading signals, and neutral technical indicators suggest waiting for a more favorable entry point.
The MACD is slightly positive but contracting, RSI is neutral at 41.441, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 1.493, with key resistance at 1.726 and support at 1.26.
Revenue increased by 85.73% YoY in Q4
Strategic discussions initiated by the largest shareholder, including potential sale of the TMS business.
Stock price surged following CFO departure and shareholder involvement.
Net income dropped by 43.47% YoY, and EPS fell by 70.59% YoY in Q4
Gross margin declined by 21.54% YoY.
No significant hedge fund or insider trading activity.
Analyst price target lowered from $7 to $3.
In Q4 2025, revenue showed strong growth of 85.73% YoY, but net income and EPS significantly declined, reflecting operational inefficiencies. Gross margin also dropped, indicating higher costs or pricing pressures.
Canaccord maintains a Buy rating but lowered the price target from $7 to $3, citing operational cash flow positivity and a new CEO as key developments.
